Podcasts about Tandem

Leslie shares her teen's type 1 diabetes diagnosis and DKA, rapid self-management with Dexcom G7 and Tandem t:slim Control-IQ, ADHD challenges, camp chaos, and parenting tactics that build independence. Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Tandem Mobi ** twiist AID System Drink AG1.com/Juicebox Use code JUICEBOX to save 40% at Cozy Earth  CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Sanofi lowers prices, oral pill for T1D prevention studied, updates from Medtronic, Tandem, and Sequel Med Tech, falsely lower A1Cs (and why that happens), Biolinq gets FDA okay for micro-needle CGM and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX French drugmaker Sanofi says it would offer a month's supply of any of its insulin products for $35 to all patients in the U.S. with a valid prescription, regardless of insurance status. The program, originally meant for uninsured diabetes patients, would now include those with commercial insurance or Medicare, the drugmaker said. Patients will be able to purchase any combination, type, and quantity of Sanofi insulins with a valid prescription for the fixed monthly price of $35, starting January 1. Lilly and Novo also have similar programs through which they offer insulin products for $35 a month for U.S. patients regardless of whether the patients have insurance. There is no law at work here – the only legislation that has changed the price of insulin came with the Inflation Reduction Act in 2022 with the Medicare cap. Helping lower the cost here, biosimilars hitting the market and the huge profitability for GLP-1 drugs for Novo and Lilly https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-offer-all-insulin-products-35-per-month-us-2025-09-26/ XX A pill typically prescribed for rheumatoid arthritis and alopecia might help slow the progression of type 1 diabetes, a new study says. Baricitinib (bare-uh-SIT-nib) safely preserved the body's own insulin production in people newly diagnosed with type 1 diabetes.. and their diabetes started progressing once they stopped taking baricitinib, results show. They produced less insulin and had less stable blood sugar levels.   Baricitinib works by quelling signals in the body that spur on the immune system, and is already approved for treating autoimmune conditions such as rheumatoid arthritis, ulcerative colitis and alopecia, researchers said.   “Among the promising agents shown to preserve beta cell function in type 1 diabetes, baricitinib stands out because it can be taken orally, is well tolerated, including by young children, and is clearly efficacious,” Waibel said. “We are hopeful that larger phase III trials with baricitinib are going to commence soon, in people with recently diagnosed type 1 diabetes as well as in earlier stages to delay insulin dependence,” she added. “If these trials are successful, the drug could be approved for type 1 diabetes treatment within five years.”   Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.   https://www.usnews.com/news/health-news/articles/2025-09-23/pill-effective-in-slowing-type-1-diabetes-progression XX An existing transplant drug has shown promise in slowing the progression of type 1 diabetes in newly diagnosed young people, potentially paving the way for the first therapy that modifies the disease after diagnosis. The Drug, called ATG, is currently used together with other medicines to prevent and treat the body from rejecting a kidney transplant. It can also be used to treat rejection following transplantation of other organs, such as hearts, gastrointestinal organs, or lungs. The researchers studied 117 people aged five to 25, who'd been diagnosed with type 1 diabetes within the past three to nine weeks. The participants were from 14 centers across eight European countries and were randomized to be given different doses of ATG (0.1, 0.5, 1.5, or 2.5 mg/kg) or a placebo. ATG was given as a two-day intravenous (IV) infusion. The main goal was to see how well the pancreas could still make insulin after 12 months, measured by C-peptide levels during a special meal test. C-peptide is released into the blood along with insulin by the pancreas.   The findings are promising, showing that ATG, even at a relatively low dose, can slow the loss of insulin-producing cells in young people newly diagnosed with type 1 diabetes. The lower dose also caused fewer side effects, making it a more practical option. https://newatlas.com/disease/antithymocyte-globulin-newly-diagnosed-type-1-diabetes/     XX The FDA has delayed its feedback on Lexicon Pharmaceuticals' application to bring Zynquista (sotagliflozin) to people with type 1 diabetes. The agency had planned to respond this month but will now wait until the fourth quarter after reviewing new data from ongoing studies. Zynquista, an oral drug meant to be used with insulin, has already been approved for heart failure (marketed as Inpefa). But in type 1 diabetes, it faces safety concerns: last year an FDA advisory committee voted 11–3 that its benefits don't outweigh the increased risk of diabetic ketoacidosis (DKA). The FDA later issued a complete response letter rejecting the drug. Lexicon is still pushing forward, hoping its additional submissions will strengthen Zynquista's case for type 1 diabetes approval. https://www.biospace.com/fda/after-fda-rejection-lexicons-type-1-diabetes-drug-hit-with-another-regulatory-delay     XX A common but often undiagnosed genetic condition may be causing delays in type 2 diabetes diagnoses and increasing the risk of serious complications for thousands of Black and South Asian men in the UK—and potentially millions worldwide. A new study found around one in seven Black and one in 63 South Asian men in the UK carry a genetic variant known as G6PD deficiency. Men with G6PD deficiency are, on average, diagnosed with type 2 diabetes four years later than those without the gene variant. But despite this, fewer than one in 50 have been diagnosed with the condition.   G6PD deficiency does not cause diabetes, but it makes the widely used HbA1c blood test—which diagnoses and monitors diabetes—appear artificially low. This can mislead doctors and patients, resulting in delayed diabetes diagnosis and treatment.   The study found men with G6PD deficiency are at a 37% higher risk of developing diabetes-related microvascular complications, such as eye, kidney, and nerve damage, compared to other men with diabetes.   "This study highlights important evidence that must be used to tackle these health inequalities and improve outcomes for Black communities. Preventative measures are now needed to ensure that Black people, especially men, are not underdiagnosed or diagnosed too late." https://medicalxpress.com/news/2025-09-hidden-genetic-delay-diabetes-diagnosis.html XX Novo Nordisk today announced the resubmission of its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Awiqli® (insulin icodec) injection, a once-weekly basal insulin treatment for adults living with type 2 diabetes. If approved, Awiqli® would become the first once-weekly basal insulin available in the United States, providing an alternative to daily basal insulin injections for adults living with type 2 diabetes.   The resubmission is based on results from the ONWARDS type 2 diabetes phase 3a program for once-weekly Awiqli® which is comprised of five randomized, active-controlled, treat-to-target clinical trials in approximately 4,000 adults with type 2 diabetes. The clinical program evaluated Awiqli® vs. daily basal insulin and the primary endpoint in these trials was change in A1C from baseline.1-5 Awiqli® is approved in the EU, along with 12 additional countries. In addition, regulatory filings have been completed in several other countries, with further regulatory decisions expected in 2025. XX Interesting news from Sequel Med Tech – they've signed an agreement with Arecor to pair the twiist pump with AT278 an ultra-concentrated (500U/mL), ultra-rapid insulin in development. They also have a deal with Medtronic to develop insulin for new pumps. This insulin isn't yet approved, it's 5 times stronger than standard fast acting  it's hoped that a clinical study will begin next year. Arecor says its insulin could potentially be the only option capable of enabling and catalyzing the next generation of longer-wear and miniaturized automated insulin delivery systems.   https://www.drugdeliverybusiness.com/sequel-arecor-develop-rapid-insulin-twiist/ XX Tandem Diabetes Care announes its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology is now cleared for use with Eli Lilly and Company's Lyumjev® (insulin lispro-aabc injection) ultra-rapid acting insulin in the United States (U.S.).   – The t:slim X2 insulin pump with Control-IQ+ technology is now cleared for use with Lyumjev for people with type 1 diabetes ages 2 and above and all adults with type 2 diabetes. The companies are continuing to work toward securing Lyumjev compatibility for the Tandem Mobi pump. https://hitconsultant.net/2025/09/29/tandem-diabetes-cares-tslim-x2-pump-cleared-for-use-with-lillys-ultra-rapid-lyumjev-insulin/ XX You can now place your order for the MiniMed™ 780G system with the Instinct sensor, made by Abbott. And if you are already a MiniMed 780G user, you can place an upgrade order today. ​This is a 15 day wear sensor, with no transmitter or overtape required. It looks the same at other Abbot sensors such as the Libre but is proprietary to Medtronic. Shipments are scheduled to start in November.   ​ https://www.drugdeliverybusiness.com/medtronic-launches-minimed-780g-instinct-abbott/   XX The global type 1 diabetes (T1D) burden continues to increase rapidly driven by rising cases, ageing populations, improved diagnosis and falling death rates. ,   The study estimates that T1D will affect 9.5 million people globally in 2025 (up by 13% since 2021), and this number is predicted to rise to 14.7 million in 2040. However, due to lack of diagnosis and challenges in collecting sufficient data, the actual number of individuals living with T1D is likely much higher, researchers say.   In fact, they estimate that there are an additional 4.1 million 'missing people' who would have been alive in 2025 if they hadn't died prematurely from poor T1D care, including an estimated 669,000 who were not diagnosed. This is particularly true in India, where an estimated 159,000 people thought to have died from missed diagnoses. The study predicts that 513,000 new cases of T1D will be diagnosed worldwide in 2025, of which 43% (222,000) will be people younger than 20 years old. Finland is projected to have the highest incidence of T1D in children aged 0-14 years in 2025 at around 64 cases per 100,000. The substantial increases in T1D forecasts between 2025 and 2040 underscore the urgent need for action. As co-author Renza Scibilia from Breakthrough T1D explains, "Early diagnosis, access to insulin and diabetes supplies, and proper healthcare can bring enormous benefits, with the potential to save millions of lives in the coming decades by ensuring universal access to insulin and improving the rate of diagnosis in all countries."   The authors note some important limitations to their estimates, including that while the analysis uses the best available data, predictions are constrained by the lack of accurate data in most countries-highlighting the urgent need for increased surveillance and research. They also note that data on misdiagnosis and adult populations remain limited, and the analysis assumes constant age-specific incidence and mortality over time. Furthermore, incidence data from the COVID-19 period were excluded from part of the modelling to avoid bias. Future updates are expected to improve as new data become available and applied. https://www.news-medical.net/news/20250919/New-study-warns-of-millions-of-undiagnosed-and-missing-people-with-type-1-diabetes.aspx XX A new study has found that semaglutide — the active ingredient found in some GLP-1 medications prescribed for diabetes and to aid weight loss — may help protect the eyes from diabetic retinopathy. Researchers estimate that as much as 40% of all people with diabetes also have diabetic retinopathy — a potentially blinding eye condition caused by blood vessel damage in the eye's retina. There is currently no cure for diabetic retinopathy. The condition is often managed through injections of anti-VEGF medications into the eye, surgery, and blood sugar monitoring and control. For this lab-based study, researchers used samples of human retinal endothelial cells that were treated with different concentrations of semaglutide. The cells were then placed in a solution with both a high glucose level and high level of oxidative stress — where there is an imbalance of antioxidants and free radicals — for 24 hours.   Past studies show that oxidative stress plays a role in the formation of diabetic retinopathy.   At the study's conclusion, researchers found that the retinal cells treated with semaglutide were twice as likely to survive than cells that were untreated. Additionally, the treated cells were found to have larger stores of energy.   Scientists also found that three markers of diabetic retinopathy were decreased in the semaglutide-treated retinal cells. First, the levels of apoptosis — a form of cell death — decreased from about 50% in untreated cells to about 10% in semaglutide-treated cells. The production of the free radical mitochondrial superoxide decreased from about 90% to about 10% in the treated retinal cells.   Researchers also found the amount of advanced glycation end-products — harmful compounds that can collect in people with diabetes and are known to cause oxidative stress — also decreased substantially.   Lastly, scientists reported that the genes involved in the production of antioxidants were more active in the semaglutide-treated cells when compared to untreated cells. Researchers believe this is a sign that semaglutide may help repair damage to the retinal cells.   “Our study did not find that these drugs harmed the retinal cells in any way — instead, it suggests that GLP1-receptor agonists protect against diabetic retinopathy, particularly in the early stages,” Ioanna Anastasiou, PhD, molecular biologist and postdoctoral researcher at the National and Kapodistrian University in Greece, and lead author of this study, said in a press release.   “Excitingly, these drugs may be able to repair damage that has already been done and so improve sight. Clinical trials are now needed to confirm these protective effects in patients and explore whether GLP-1 receptor agonists can slow, or even halt, the progression of this vision-robbing condition.” https://www.medicalnewstoday.com/articles/ozempic-semaglutide-may-help-protect-against-diabetes-related-blindness-retinopathy   XX Biolinq has received De Novo Classification from the U.S. Food and Drug Administration for its lead product, Biolinq Shine, a patch on the forearm that provides real-time glucose feedback through a primary color-coded LED display, visible with or without a phone. This one is tricky – it's called a needle free CGM but it also says it uses micro needles. By the way, De Novo isn't exactly the same as what we think of for FDA approval for medical devices. It's not as rigorous but it's a streamlined route for novel, low to moderate risk devices with no existing equivalent. We'll see how this one turns out. https://www.hmenews.com/article/biolinq-s-multi-function-biosensor-receives-fda-de-novo-classification

The Go Gopher Podcast with Mike Grimm - Episode #190 features a return visit from Gopher football tight end Jameson Geers, who brings fellow tight end Drew Biber along with him.  We recap the Rutgers win and preview this weekend's game at #1 Ohio State.   From Aquarius Home Services Studio (https://aquariushomeservices.com/)   Sponsored by: (https://www.sunbeltminnesota.com/ & https://www.tnma.com), Affinity Plus Federal Credit Union (https://www.affinityplus.org/gogophers), OnX Maps (https://www.onxmaps.com/), & Cub Foods (www.cubfoods.com)

This week on Happy Mum Happy Baby we say hiya to actress, presenter and mother of four Joanna Page!Joanna opens up to Gi about life after Gavin & Stacey, and shares how she juggles the chaos of raising four children (and many pets!) alongside her acting career.She also reflects on the complications she faced during pregnancy, as well as her experience of becoming pregnant again at 44.Joanna's new autobiography Lush!: My Story - From Swansea to Stacey and Everything in Between is available now! Hosted on Acast. See acast.com/privacy for more information.

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

When roles shift at home and at work, even strong couples can feel the strain. In this episode, returning guests Shay and Phil Bynes (Kingdom Driven Entrepreneur) pull back the curtain on their four-year journey of transitioning Shay out of the CEO seat and Phil in—while raising three kids and continuing to lead a global movement. They share what changed, what didn't, and how they protected connection through it all. You'll hear how they navigated identity, authority, and expectations as spouses and co-leaders—without letting business tension become marital tension. From hearing God's nudge to act, to wrestling with control, to defining new decision rights, Phil and Shay explain the practical guardrails (and plenty of grace) that made the handoff work. We also get tactical about staying close during busy seasons: weekly “marriage board meetings,” spontaneous micro-check-ins, and simple, intentional fun that doesn't require a plane ticket. If you're a married entrepreneur aiming to grow your business without shrinking your marriage, this conversation is a masterclass in change done together. 12 Powerful Questions to Connect You with God's Heart & Mind in Business: https://kingdomdrivenentrepreneur.com/usccc Free Chapter of Shae's Book, Grace Under Pressure: A Story About Leadership and the Hidden Cost of Ambition https://shaebynes.com/gupbook Grace over Grind https://kingdomdrivenentrepreneur.com/our-books/ Key Takeaways: Transitions need clarity: Decide who owns which decisions now (vision, people, money, operations) and write it down. Step back—then calibrate: Founders often swing too far away after a handoff; expect to iterate until the advisor/CEO rhythm fits. Protect a weekly marriage meeting: Same time, same day, non-negotiable. Use ground rules so issues get resolved before they fester. Honor design differences: Lead styles will differ by God's design; resist the urge to “correct” your spouse into your style. Let things “sputter” (strategically): Maturity sometimes requires leaders to stop rescuing, so teams learn to think and own outcomes. Friendship fuels connection: Micro-moments (10-minute check-ins, pausing a show to talk) keep intimacy alive during busy stretches. Serve first leadership: Out-serving one another at home creates safety and teamwork that shows up in the business. Plan fun on purpose: Comedy nights, simple dates, and kid-care logistics belong on the calendar like any key meeting. Phil Bynes is CEO of Kingdom Driven Entrepreneur, a global movement equipping entrepreneurs to partner with God in business and create greater Kingdom impact in the marketplace. He is also the owner and lead therapist at Crazy Good Massage, where he has served clients with excellence for over 20 years. Shae Bynes, affectionately known as the Chief Fire Igniter, equips leaders to build grace-empowered cultures where people and results flourish. She has impacted over one million people worldwide through her books, courses, podcasts, and speaking. In her executive advising work, she brings a unique blend of strategic clarity, spiritual intelligence, and transformational insight. High school sweethearts since age 16, Phil and Shae have been married for 26 years and are the proud parents of three daughters. Want to live a better balanced life and win in marriage AND business at the same time? Purchase our (audio) book Tandem: The married entrepreneurs' guide for greater work-life balance. https://www.thetandembook.com/ Download the 5 Daily Habits to Thrive in Tandem https://marriedentrepreneur.co/5-daily-habits-download  Need some insight into how to balance it all? Schedule a free discovery call. https://marriedentrepreneur.co/lets-talk  

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

The Race is back ! For the kickoff of The Amazing Race Season 38, Brice is switching things up on the Pitstop. While Brooke is living her best life in Europe, our good friend Sasha Joseph (@funsize_04) steps in to break down all the twists and turns of Episode 1. From icy strikes on the rink, cheese wheels in Edam, to flower power in the greenhouse, Brice and Sasha are just vibin' as they unpack the premiere. We're talking Express Pass drama, Hazard struggles, and first impressions of this Big Brother–meets–Race cast. You already know the vibes are high and the energy is flowing—don't miss it!

Purple Pants Podcast | Twins, Twists & Tandem Bikes The Race is back ! For the kickoff of The Amazing Race Season 38, Brice is switching things up on the Pitstop. While Brooke is living her best life in Europe, our good friend Sasha Joseph (@funsize_04) steps in to break down all the twists and turns of Episode 1. From icy strikes on the rink, cheese wheels in Edam, to flower power in the greenhouse, Brice and Sasha are just vibin' as they unpack the premiere. We're talking Express Pass drama, Hazard struggles, and first impressions of this Big Brother–meets–Race cast. You already know the vibes are high and the energy is flowing—don't miss it! You can also watch along on Brice Izyah's YouTube channel to watch us break it all down https://youtube.com/channel/UCFlglGPPamVHaNAb0tL_s7g Previously on the Purple Pants Podcast Feed:Purple Pants Podcast Archives LISTEN: Subscribe to the Purple Pants podcast feed WATCH: Watch and subscribe to the podcast on YouTubeSUPPORT: Become a RHAP Patron for bonus content, access to Facebook and Discord groups plus more great perks! Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Rebecca and Shaun catch up on life, business, and creative growth. Rebecca just returned from a design retreat at a beautifully designed cabin (by Form & Field), where she worked on brand strategy and made tangible progress on her website. They also dive into frustrating vendor experiences, the evolving role of AI agents in design work, and a hot take on whether being barefoot in brand photos is ever appropriate.In the second half of the episode, they debate the ethics, emotional labor, and financial risks that come with sourcing, receiving, and delivering furniture—especially when imperfections, shipping issues, and miscommunications arise. They also explore how one small branding detail like footwear in photos can signal so much about professionalism, identity, and client expectations.In this episode they discuss:Rebecca's design retreat: goals, structure, productivity, and what she accomplished (brand strategy guide, website refresh)The importance of having external accountability (“show and tell” among designer friends) to push projects forwardChallenges working with vendors and receiving warehouses: damaged goods, imperfect manufacturing, inspection failures, and the cost (financial & emotional) of fixing themWhy healthy project and product margins are non-negotiable in design to absorb unexpected costsThe rise of AI agents in business: potential, limitations, risks (data access, automation gone wrong)The debate on brand photo styling: barefoot vs shoes, what each choice communicates about professionalism and personal brandReflections on aging, style evolution, and gaps in the market (e.g. men's clothing quality and age-appropriateness)Mentioned:The Airbnb Rebecca stayed in for her retreathttps://formandfield.com/work/donner-lake-cabinRebecca worked on her brand guide based on ideas from Renee Bush from Tandem. Listen to Renee's episode 150https://podcasts.apple.com/us/podcast/150-renee-bush-from-tandem-on-building-cohesive-brands/id1505427626?i=1000717943157Agents in AIhttps://www.tiktok.com/t/ZT6u2YScK/Our links:Subscribe and leave a review - Apple PodcastsLike, Comment, & Follow - Hot Young Designers Club InstagramRebecca's InstagramShaun's InstagramFor more information - Check out the websiteBecome a “Loyal Hottie” - Support us on PatreonDesign Resources - Check out our shop

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Instrumente zusammengepackt und ab aufs Tandem, von Konzert zu Konzert radeln. Tante Friedl ist eine besondere Band. Magdalena und Dan sind Profimusiker und im Sommer immer mit dem Fahrrad auf Tour. In dieser Folge erzählen sie von logistischen Problemchen, Exit-Strategien und kleinen Tierchen, die besonders frech sind. Du hast Fragen, Anregungen oder einfach was zu sagen? Dann schreib uns eine Mail an mail@bikersparadisepodcast.de BIKERS PARADISE wird moderiert von Martin Gertz und Alex Hüfner.

Tante Friedl und das Musizieren auf und neben dem Fahrrad Instrumente zusammengepackt und ab aufs Tandem, von Konzert zu Konzert radeln. Tante Friedl ist eine besondere Band. Magdalena und Dan sind Profimusiker und im Sommer mit dem Fahrrad auf Tour. In dieser Folge erzählen sie von logistischen Problemchen, Exit-Strategien und kleinen Tierchen, die besonders frech sind. Du hast Fragen, Anregungen oder einfach was zu sagen? Dann schreib uns eine Mail an mail@bikersparadisepodcast.de BIKERS PARADISE wird moderiert von Martin Gertz und Alex Hüfner. +++ WERBUNG +++Ghost of Yōtei - das Action-Adventure - exklusiv für PS5 ab 2. Oktober hier erhältlich:https://www.playstation.com/de-de/games/ghost-of-yotei/Dieser Podcast wird vermarktet von der Podcastbude.www.podcastbu.de - Full-Service-Podcast-Agentur - Konzeption, Produktion, Vermarktung, Distribution und Hosting.Du möchtest deinen Podcast auch kostenlos hosten und damit Geld verdienen?Dann schaue auf www.kostenlos-hosten.de und informiere dich.Dort erhältst du alle Informationen zu unseren kostenlosen Podcast-Hosting-Angeboten. kostenlos-hosten.de ist ein Produkt der Podcastbude.

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Esta semana en nuestro podcast abordamos un tema que muchas madres viven con ilusión, pero también con muchas dudas e inquietudes: la lactancia en tándem.Sabemos que amamantar a dos hijos de diferentes edades —el mayor y el recién nacido— puede generar un torbellino de emociones. Por eso, en este nuevo episodio te hablamos con honestidad sobre cómo afrontar este momento tan particular, explorando no solo la teoría, sino también la realidad del día a día.Hablamos de lo que suele esperarse antes del nacimiento del segundo bebé y de cómo se vive realmente el inicio del tándem. Porque sí, puede ser hermoso, pero también agotador, abrumador y lleno de matices.

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Der tristar-Titel 'People & Culture' beschreibt Christian schon ziemlich treffend. Denn er sorgt dafür, dass sich die Mitarbeiter im Unternehmen mehr als wohlfühlen. Aber wusstet Ihr, dass er als gelernter Restaurantfachmann zunächst mit der Hotellerie nur wenig zu tun hatte und auch keine Hotelausbildung folgte? Christian ist mein bisher einziger Gast, der ausschließlich mit einer Restaurantfachausbildung in die Führungsetage eines Hotelunternehmens aufgestiegen ist (alle anderen hatten eine Gastro- und Hotelausbildung). Im Rahmen dieser begann in Bonn im 'La Redoute', das damals zu den Günnewig Hotels & Restaurants gehörte. Die Gastrokarriere setzte sich auf der MS Europa fort, bis das Phantasialand rief. Und hier nahm im Ling Bao die Hotelkarriere von Christian ihren Anfang. In der 2013 von Fattal aufgekauften Queens Moats Houses Management GmbH wurde die Sales-Expertise erweitert und führte danach in die Schweiz ins Palace Luzern und, oha, zu Apple. So war der Grundstein gelegt für seine seit fast neun Jahren andauernde Berufung bei der tristar GmbH in Berlin. Was sind dort als Head of People & Culture seine Aufgaben, wie schnell reagiert er auf Mitarbeiterbewertungen und wie schafft es der Betreiber tristar, die verschiedenen Hotelmarken mit ihren Eigenheiten unter einen Hut zu bekommen? Ach ja und dann ist da noch die HSMA, in der Christian seit sechs Jahren ehrenamtlich tätig ist. Jetzt stellt er sich gemeinsam mit Christian von Rumohr und Alexandra Weber als Präsidiums-Tandem zur Verfügung. Was sind ihre Ziele, sollten sie denn gewählt werden? Gutes Hören beim Podcast Nr. 105 - dem aus einem Dorint-Hotelzimmer...

Wir haben einen neuen Tabellenführer, der kroatische Harry Kane mischt die 2. Bundesliga auf, Miroslav Klose sammelt am 6. Spieltag endlich seinen ersten Dreier mit den 1. FC Nürnberg und auf dem Betze fährt man Tandem. Es gibt viele Dinge über die wir zu sprechen haben, jetzt bei Spieltagssieger mit unserem 2. Liga-Experten Tusche. 00:00:00: Intro & Liga-Talk 00:11:45: Tusches Trio 00:15:39: Spieltagsrückblick 00:52:01: Spieltagsvorschau 00:57:06: Einakufswagen

Get on the waitlist for a Thriving in Tandem event near you. https://marriedentrepreneur.co/marriage-and-business-events  Want to live a better balanced life and win in marriage AND business at the same time? Purchase our (audio) book Tandem: The married entrepreneurs' guide for greater work-life balance. https://www.thetandembook.com/ Download the 5 Daily Habits to Thrive in Tandem https://marriedentrepreneur.co/5-daily-habits-download  Need some insight into how to balance it all? Schedule a free discovery call. https://marriedentrepreneur.co/lets-talk Every married entrepreneur knows the challenge of managing different energy levels—especially when one spouse is ready to go full throttle and the other needs to pace themselves. In this episode, Robert and Kay Lee get real about how this dynamic plays out in their own relationship, from social events and vacations to business strategy sessions and conferences. They reflect on their early frustrations and how intentional communication helped them transform energy differences from a source of conflict into a strength. They share practical tips for managing expectations, planning ahead, and respecting each other's rhythms—whether you're attending a networking event, hosting a retreat, or simply planning your weekend. From code words to separate cars, from downtime gaps on vacation to avoiding heavy convos at bedtime, this episode offers insight into how married couples can honor each other's needs while still pursuing shared goals. Plus, they announce new in-person events—like their upcoming wine pairing dinner, concerts in the park, and even a ski trip in 2026. If you've ever wished your spouse could just keep up (or slow down), this is the episode that will help you find peace, pace, and partnership. Key Takeaways: Don't assume your spouse should match your energy—discuss your needs and make a plan ahead of time. Rest isn't always about sleep; it can also mean freedom from rigid schedules or overstimulation. Schedule important conversations when you're both alert—avoid conflict-heavy talks late at night or during busy moments. Protect the bedroom as a place of intimacy and peace, not stress or business talk. Even high-energy spouses benefit from margin; intentional rest improves clarity, focus, and connection.

Grief's Hidden Impact On The Youngest Among Us Grief in children doesn't always look like sadness and can present even months or years after a big loss. Child therapist Natasha Daniels shares both her professional insights and personal story of loss, highlighting the challenges families face in finding the right care and working through these emotions. Part 2: Food Insecurity In The U.S: How Local Pantries And National Policy Work In Tandem Across the U.S., food pantries and nonprofits are stretched thin as more families fall into the “working poor” category, earning just above the poverty line yet unable to make ends meet. Stephanie Hoopes of United for ALICE and Camerin Mattson of the Greater Chicago Food Depository explain how local support systems and federal programs like SNAP intersect to feed the many millions of Americans in need. Viewpoints Explained: Why Are Teen Reading Scores At A 30-Year-Low? High school reading scores have dropped to their lowest level in decades, with absenteeism and screen time fueling the decline. We cover how some states are tackling the problem with early literacy reforms and teacher training. Culture Crash: What Sabrina Carpenter Learned From Jack Antonoff From disco shimmer to rock swagger, singer Sabrina Carpenter's new album shows just how far her sound can stretch. Learn more about your ad choices. Visit megaphone.fm/adchoices

Across the U.S., food pantries and nonprofits are stretched thin as more families fall into the “working poor” category, earning just above the poverty line yet unable to make ends meet. Stephanie Hoopes of United for ALICE and Camerin Mattson of the Greater Chicago Food Depository explain how local support systems and federal programs like SNAP intersect to feed the many millions of Americans in need. Learn More: https://viewpointsradio.org/part-2-food-insecurity-in-the-u-s-how-local-pantries-and-national-policy-work-in-tandem Learn more about your ad choices. Visit megaphone.fm/adchoices

Neue Gravelbikes integrieren Nabendynamo, Bordstrom und Ladebuchse. Bella fährt bei „Rad am Ring“ auf dem Nürburgring mit — auf kleinen Rädern. (00:00:00) Intro (00:01:23) Im Regen über den Col d'Agnes (00:05:40) Klingeln bei Klötzer: Neue Gravelbikes (00:06:55) Gravelbikes mit Bordstrom (00:09:39) Vitale Fahrradgattung Gravelbike (00:13:20) Stromversorgung, Pufferakku und Nabendynamo (00:21:19) Gravelbikes als neue Trekkingräder? (00:25:19) Was fehlt noch? (00:28:34) Zukunftsprogonose (00:36:28) Ausfahrt des Monats: Mit dem Rad zum Nürburgring (00:38:50) Unterwegs mit Hängematte und Tarp (00:41:03) Bellas wichtigster Tipp (00:43:02) Route bis zum Nürburgring (00:45:27) 24 Stunden Rad am Ring (00:49:04) Stijn Cycles PEG (00:54:56) BØK H2 (00:57:26) Zu dritt 24 Stunden auf dem Nürburgring (00:58:22) Die schönste Runde auf dem Nürburgring (01:01:56) Verabschiedung (01:03:05) Musik: Die Höchste Eisenbahn – Die Bahn Hier findet ihr die Räder, über die wir in dieser Ausgabe sprechen: – Rose Backroad Unsupported: https://www.rosebikes.de/p/rose-backroad-unsupported-2725748 – Canyon Grizl CF8 ESC: https://www.canyon.com/de-de/gravel-bikes/adventure/grizl/escape/grizl-cf-8-esc-w%2F-eclips/4144.html – Stijncycles PEG: https://lifecyclemag.de/stijncycles/ – BOK: https://ridebok.com/ Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt Hier findet ihr unsere Playlist mit den Songs zu jeder Ausgabe: https://open.spotify.com/playlist/0rFFrMDgoZX2PdHMwvaEmG?si=CLr3tTRjS0CiO69tvViuBg&pi=eTmlliErRqSEF&nd=1&dlsi=ec5fff6698d54ddf >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-neue-gravelbikes-und-nuerburgring-auf-20-zoll

Neue Gravelbikes integrieren Nabendynamo, Bordstrom und Ladebuchse. Bella fährt bei „Rad am Ring“ auf dem Nürburgring mit — auf kleinen Rädern. (00:00:00) Intro (00:01:23) Im Regen über den Col d'Agnes (00:05:40) Klingeln bei Klötzer: Neue Gravelbikes (00:06:55) Gravelbikes mit Bordstrom (00:09:39) Vitale Fahrradgattung Gravelbike (00:13:20) Stromversorgung, Pufferakku und Nabendynamo (00:21:19) Gravelbikes als neue Trekkingräder? (00:25:19) Was fehlt noch? (00:28:34) Zukunftsprogonose (00:36:28) Ausfahrt des Monats: Mit dem Rad zum Nürburgring (00:38:50) Unterwegs mit Hängematte und Tarp (00:41:03) Bellas wichtigster Tipp (00:43:02) Route bis zum Nürburgring (00:45:27) 24 Stunden Rad am Ring (00:49:04) Stijn Cycles PEG (00:54:56) BØK H2 (00:57:26) Zu dritt 24 Stunden auf dem Nürburgring (00:58:22) Die schönste Runde auf dem Nürburgring (01:01:56) Verabschiedung (01:03:05) Musik: Die Höchste Eisenbahn – Die Bahn Hier findet ihr die Räder, über die wir in dieser Ausgabe sprechen: – Rose Backroad Unsupported: https://www.rosebikes.de/p/rose-backroad-unsupported-2725748 – Canyon Grizl CF8 ESC: https://www.canyon.com/de-de/gravel-bikes/adventure/grizl/escape/grizl-cf-8-esc-w%2F-eclips/4144.html – Stijncycles PEG: https://lifecyclemag.de/stijncycles/ – BOK: https://ridebok.com/ Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt Hier findet ihr unsere Playlist mit den Songs zu jeder Ausgabe: https://open.spotify.com/playlist/0rFFrMDgoZX2PdHMwvaEmG?si=CLr3tTRjS0CiO69tvViuBg&pi=eTmlliErRqSEF&nd=1&dlsi=ec5fff6698d54ddf >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-neue-gravelbikes-und-nuerburgring-auf-20-zoll

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

When was the last time you and your spouse really laughed together? In this week's episode of Thriving in Tandem, Robert and Kay Lee dive deep into a topic too many married entrepreneurs overlook—fun. After returning from an 18-day dream vacation in Italy and hosting their first “Thriving in Tandem Date Night,” they realized just how many couples have stopped making space for joy. Between business demands, family responsibilities, and endless to-do lists, fun often gets pushed aside. Robert and Kay Lee share creative, budget-friendly ways to bring fun back into your marriage without waiting for the “perfect” time or a big trip. From driveway date nights to free concerts in the park, they remind us that joy isn't about extravagance—it's about intentionality. They also reveal how planning events for their married entrepreneur community has given them built-in reasons to prioritize their own date nights and adventures. This episode is full of practical ideas, relatable laughs, and a powerful reminder that fun is essential for a thriving marriage and business. Whether it's putting date nights on the calendar, joining in-person gatherings, or even “forcing” fun through memberships or pre-paid trips, Robert and Kay Lee challenge you to stop waiting and start creating shared memories now. Join our Thriving in Tandem event waitlist https://marriedentrepreneur.co/event-waitlist  Want to live a better balanced life and win in marriage AND business at the same time? Purchase our (audio) book Tandem: The married entrepreneurs' guide for greater work-life balance. https://www.thetandembook.com/ Download the 5 Daily Habits to Thrive in Tandem https://marriedentrepreneur.co/5-daily-habits-download  Need some insight into how to balance it all? Schedule a free discovery call. https://marriedentrepreneur.co/lets-talk Key Takeaways: Fun fuels connection – Laughter and shared experiences lower stress, boost creativity, and strengthen your bond. Intentionality is everything – If it's not on the calendar, it probably won't happen. Fun doesn't have to be expensive – Explore free and local activities; creativity counts more than cost. Community matters – Being around other married entrepreneurs creates instant understanding and encouragement. Sometimes you have to “force” fun – Pre-committing with reservations, memberships, or events helps ensure you follow through.

The Chicago White Sox Catcher Kyle Teel is breaking records as a rookie. Currently, he had a 20 base streak that only Bo Bichette has kept pace with and only rookie since Jose Abreu' rookie season in 2014. Should the White Sox extend him this offseason? Tim Kanak, Host of Fantasy Aceball Podcast, joined us to go over his top 10 nondebuted prospect rankings of the Chicago White Sox farm system.

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Other Episodes You Might Like: Previous Episode - From Your Mouth to Your Gut: Hearing Health Whisper Next Episode - The Truth About Muscle and Menopause: What Every Woman Needs to Know About the Science Data More Like This - Take a Walk with a 57-year old Book Author | Just 1400 Miles    Resources: Join the Hot, Not Bothered! Challenge for your best start, restart or reset in or after menopause with 10 Days of coaching, short workouts, and clarity on how to exercise optimally. Flipping 50 Womens Retreats helps you step out of routine, challenge your body and mindset, and rediscover how you want to live midlife—supported by fitness, hormones, nutrition, and women just like you.   Date night for this couple is riding tandem on a bike for 80 days.  Even “uncoupled” and singles will enjoy this episode of inspiration. Disclaimer, you're going to want to dream bigger, take a risk, believe in yourself and have adventures after listening to this episode.  We've got some ideas for you! Check out the 2026 women's retreats here. This episode is about more than riding tandem with your partner. Prepare to be inspired.    My Guest: Lady JB Owen is an internationally bestselling author, award-winning businesswoman, celebrated humanitarian, coveted speaker, trainer, and legacy mentor. She's been recognized by Forbes, Entrepreneur Magazine, and Apple News for her mission-driven work in publishing and impact.  Peter Giesin is the co-founder and CTO at Ignite Publishing, Software Evangelist for Aspiring Authors, Author, and Adventurer. He merges technology with storytelling to empower aspiring authors worldwide. Peter is ambitiously set on a personal goal: to live to 125 years old. He has an unwavering passion for exploring the far limits of living a long and vital life.   Connect with Lady JB & Peter: Website - Ignite Facebook - Ignite You and Epic Tandem Instagram - @igniteyou.life   Questions We Answer in This Episode: [00:12:16] You're currently cycling over 4,500 kilometers on a tandem bike to Ignite Humanity - define that.  [00:14:00] What inspired you to connect your purpose with a physically and mentally demanding challenge?  [00:20:00] How has the challenge changed over the years? With age, recovery changes, how has that hit differently?  [00:25:30] How do you stay motivated and connected to your ‘why' during the hardest parts of the journey, both physically and emotionally? [00:35:220] You're proving that shared purpose can strengthen not only communities but also relationships. What lessons have you learned about partnership, resilience, and communication while pedaling thousands of kilometers together? [00:45:56] People are inspired by your ride—what stories or people along the way have inspired you?  

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: kids' A1C and tech access correlation, first generic GLP-1 for weight loss approved, Metformin cuts long covid risk, Tandem Diabetes & Eversense updates, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Accessibility to modern diabetes technology directly correlates with A1c among children with type 1 diabetes globally. Big, cross-sectional study, conducted in 81 pediatric diabetes centers in 56 countries, found that a greater extent of reimbursement for continuous glucose monitoring (CGM), insulin pumps, glucose meters, and insulin was associated with lower A1c levels. Partha S. Kar, MD, Type 1 Diabetes & Technology lead of the National Health Service England, told Medscape Medical News, “As is now being shown in countries such as UK with widespread uptake of technology, there is now population-wide shift in A1c not seen before.”   He added, “If policymakers are serious about bringing A1c at a population level to sub-7.5% - 8% levels, then without technology it would be incredibly difficult to achieve, in my experience and opinion. Leaving the median A1c of a population at above 7.5%-8% goes with complications so that's a decision regarding investment many will have to make in the near future.”   In an accompanying editorial, Elizabeth R. Seaquist, MD, professor of diabetes, endocrinology, and metabolism and co-director of the Institute for Diabetes, Obesity, and Metabolism at the University of Minnesota, Minneapolis, called it “striking” that access to technology in and of itself was associated with improved glycemic control, given that multidisciplinary team care is also needed to provide education and behavioral or psychological support.     https://www.medscape.com/viewarticle/diabetes-tech-access-linked-a1c-kids-t1d-globally-2025a1000nn6 XX A man with type 1 in Illinois has received the first FDA-approved islet-cell replacement treatment, Lantidra, and  he is now producing his own insulin. The treatment works by restoring the body's beta cells, potentially eliminating the need for insulin injections.   The FDA approved Lantidra (donislecel) in 2023. Lantidra uses donor cells and requires lifelong immunosuppressive drugs.     Lantidra is only available at University of Illinois Chicago Health. Other universities, such as the University of Pennsylvania, continue to do islet cell transplants as part of clinical trials. Early data has shown that a majority of participants in the Lantidra clinical study were able to achieve some level of insulin independence, but it's unclear whether the benefits of donislecel outweigh the treatment's safety risks. Nearly 87 percent of participants reported infection-related adverse events, and post-operation complications included liver lacerations, bruising of the liver (hepatic hematoma), and anemia. One patient died of multi-organ failure from sepsis, which Lantidra maker CellTrans stated was “probably related” to the use of either immunosuppression or study drugs.   In addition, some industry leaders have raised the question of whether it's ethical to commercialize the use of deceased donor islet cells. https://diatribe.org/diabetes-research/first-fda-approved-islet-cell-transplant-performed?utm_campaign=feed&utm_medium=social&utm_source=later   XX Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk's injected Saxenda (liraglutide).   The compound, which is a GLP-1 forerunner of Novo's semaglutide products Ozempic and Wegovy, has been approved by the FDA to treat adults with obesity and those who are overweight and have weight-related medical problems.     Saxenda also is endorsed for pediatric patients ages 12 through 17 who are obese and weigh at least 60 kg (132 pounds). The treatment is for both triggering and maintaining weight loss. Saxenda is not the first GLP-1 drug that is available as a generic. In June of last year, Teva also was the first company to launch a knockoff version of Novo's Victoza, which is the same compound as Saxenda but has been approved only for patients with Type 2 diabetes. Sales of the branded versions of both Victoza and Saxenda have declined significantly in recent years as demand for Novo's semaglutide and Eli Lilly's tirzepatide products have skyrocketed. In addition, marketers of compounded products have been aggressively competing for market share in the GLP-1 space. https://www.fiercepharma.com/pharma/saxenda-knockoff-teva-launches-first-generic-glp-1-obesity   XX Metformin could cut the risk of Long COVID by 64% in overweight or obese adults who started the drug within 90 days of infection. The large observational study, published in Clinical Infectious Diseases, analysed health records of over 624,000 UK adults with COVID-19 between March 2020 and July 2023. Among these, nearly 3,000 patients who began metformin treatment soon after diagnosis were tracked for a year. Compared to non-users, their likelihood of developing Long COVID, defined as persistent symptoms 90 days or more after infection, was dramatically lower. https://www.ndtv.com/health/metformin-cuts-risk-of-long-covid-by-64-why-the-diabetes-pill-is-not-for-everyone-9242332 XX Forty-four percent of people age 15 and older living with diabetes are undiagnosed, so they don't know they have it, according to data analysis published Monday in the journal The Lancet Diabetes & Endocrinology. The study looked at data from 204 countries and territories from 2000 to 2023 in a systematic review of published literature and surveys. “The majority of people with diabetes that we report on in the study have type 2 diabetes,” said Lauryn Stafford , the lead author of the study.   “We found that 56% of people with diabetes are aware that they have the condition,” said Stafford, a researcher for the Institute for Health Metrics and Evaluation. “Globally, there's a lot of variation geographically, and also by age. So, generally, higher-income countries were doing better at diagnosing people than low- and middle-income countries.” People under 35 years were much less likely to be diagnosed if they had diabetes than people in middle age or older. Just “20% of young adults with diabetes were aware of their condition,” Stafford said. https://www.cnn.com/2025/09/08/health/diabetes-undiagnosed-half-of-americans-wellness XX A team of Hong Kong scientists is developing an injectable treatment that could potentially improve blood flow in diabetes patients' feet, in the hopes that it will reduce the need for amputation by rebuilding tissue in the arteries.   They also hope to apply the treatment to peripheral artery disease or PAD, a condition caused by the build-up of fatty deposits in arteries that affect blood circulation in the feet. “Traditional treatments for people suffering from poor blood flow in their legs are stent implantation or bypass surgery, which is invasive,” said Wong, who is also the co-founder of a biotechnology company called NutrigeneAI. He said it was his dream to turn research in the academic field into actual clinical treatments. But he added that the team still needed three to four years for further research on the treatment.   https://www.scmp.com/news/hong-kong/health-environment/article/3324671/hong-kong-scientists-developing-new-blood-flow-treatment-aid-diabetes-patients XX   Tandem Diabetes announces Health Canada authorization for distribution of the Tandem t:slim mobile application for Android and iPhone users. The Tandem t:slim mobile app allows users to deliver a bolus from their compatible smartphone, and to wirelessly upload their pump data to the cloud-based Tandem Source platform.1 The app is expected to be available later this year.   The Tandem t:slim mobile app will be available for compatible smartphones in the Apple App Store and Google Play store later in 2025. Once available, Tandem will email eligible customers with instructions on how to download and use the app.  https://www.businesswire.com/news/home/20250904665715/en/Tandem-tslim-Mobile-App-Now-Authorized-by-Health-Canada-for-iPhone-and-Android-Phones   XX Some changes to how the Eversense CGM will be rolled out.. right now it's being distributed by Ascensia Diabetes Care.  Senseonics will take back commercial control of the year long implantable CGM on January 1 in the US and expanding worldwide throughout 2026. The change was a mutual decision, according to the two companies, which said they have signed a memorandum of understanding before a definitive agreement is hammered out by the end of the year. To get started, Senseonics is also set to acquire members of Ascensia's commercial staff—including its CGM president, Brian Hansen, who is slated to become Senseonics' new chief commercial officer. https://www.fiercebiotech.com/medtech/senseonics-retake-eversense-cgm-commercial-control-ascensia-diabetes-care XX Utrecht-based medical device company ViCentra has closed an $85 million Series D round of funding led by Innovation Industries, along with existing investors Partners in Equity and Invest-NL. The round also drew support from EQT Life Sciences and Health Innovations.   The recent capital injection will be used to expand ViCentra's manufacturing capabilities, support regulatory approvals, and strengthen commercial rollout across Europe.   The funds will also be used to launch the next-generation Kaleido 2 patch pump in Europe and prepare for entry into the U.S. market.   The global insulin delivery market is growing quickly due to the increasing number of diabetes cases and demand for effective and user-friendly solutions. The market for insulin pumps is projected to exceed $14 billion by 2034. Patch pumps are the fastest-growing segment, signalling a trend toward compact and wearable devices. And here's where ViCentra is positioned to meet this need, offering a user-friendly, sleek design-led alternative to traditional systems.   Kaleido: design-led insulin delivery Kaleido is the smallest and lightest insulin patch pump developed as a lifestyle product with a particular focus on usability and personalisation.   Designed to feel more like personal technology than a traditional medical device, Kaleido features premium materials, and users can select their own favourite aluminium shells from a range of ten preset colour options.   It integrates with Diabeloop's hybrid closed-loop algorithms (DBLG1 and DBLG2) and is compatible with Dexcom CGM sensors, positioning it within the next generation of automated insulin delivery systems.   “Kaleido is a true disruptor — small, discreet, featherlight, and beautifully designed. It empowers people with diabetes by offering a more personal and distinctive choice in both function and style. Built with empathy and precision, it honours those who live with diabetes every day. With this funding, we can now meet surging European demand and fast-track our entry into the U.S. market. This is a pivotal moment — for ViCentra, and for the community we serve,” said Tom Arnold, Chief Executive Officer at ViCentra.   Improving the quality of life for diabetic patients ViCentra, led by Tom Arnold, is on a mission to improve the lives of those with diabetes.   The company reported that demand for Kaleido in Germany, France, and the Netherlands has already exceeded initial expectations.   ViCentra will present updates on Kaleido at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD), taking place September 15–19, 2025, in Vienna.   The company plans to engage with clinicians, investors, and strategic partners to further its role in the evolving diabetes care landscape.   “ViCentra is redefining insulin pump therapy with a platform that truly centres the user experience – combining clinical performance with design simplicity and wearability,” commented Caaj Greebe, Partner at Innovation Industries. “At Innovation Industries, we invest in pioneering companies that blend world-class technology with clear commercial potential. ViCentra exemplifies this by delivering a next-generation system addressing the urgent need for better treatment options in diabetes care. We're proud to lead this investment round and partner with Tom and the team as they deepen and expand their presence in Europe and prepare for U.S. entry.”   https://techfundingnews.com/dutch-vicentra-secures-85m-to-bring-insulin-patch-pump-to-more-markets/ XX Luna Diabetes announces they've raised more than 23-million dollars in early venture capital to help continue clinical trials and build out its capacity. This is the company that wants to offer a night time only, tiny, temporary insulin pump – to supplement insulin pen use. According to the company, more than 80% of the improvements in blood sugar from automated insulin delivery systems occur while the user is sleeping. Luna launched a pivotal trial late last year. https://www.fiercebiotech.com/medtech/nighttime-insulin-patch-pump-maker-luna-diabetes-raises-236m   XX Following 15 days and 150 fingerpricks, they're here. The results of the “9 sensor samba“. And what a set of a results…   Well maybe that's overplaying it a little.   Let's just say that the outcome of this n=1 experiment wasn't quite what I expected. One of the established players came out much worse than expected, while a newcomer did a lot better.   Let's dig in, and take a look at the variation. https://www.diabettech.com/cgm/the-nine-sensor-samba-results-revealed/   XX Hard work and perseverance define ranch life, but one man in eastern Montana takes it to another level. At 90, he's still living independently on the ranch he built from the ground up. Even more remarkable? He's a type 1 diabetic.   Bob Delp still begins each day just like he did decades ago, waking up on his ranch near Richey, Montana.   “I always thought if I could ever get a ranch and run a hundred cows, that's what I wanted to do from the time I was a kid,” said Delp.   He made that dream real, the hard way; after coming home from the army, he taught school, hayed for seven cents a bale and saved every cent he could.     “I worked at it real hard because I always felt like it was going to be part of getting me to that ranch that I always wanted,” said Delp.   He did it all while managing type 1 diabetes, a diagnosis that came with few answers and little hope back in the 1950s.   “The doctors tell me being a type 1 diabetic for 66 years isn't supposed to happen. Back then, it was a real challenge,” added Delp.   Statistically, it's almost unheard of. Fewer than 90 people in the world have lived more than 70 years with type 1 diabetes.     Bob credits his late wife, Donna, for helping him beat the odds.   “She has been key in that I always ate on time.”   They've faced their share of storms, both in health and out on the land. Not long after moving to Richey, a heavy snowstorm nearly tore everything apart just after they'd stepped out for dinner.   “If Donna hadn't said it was time to eat, we wouldn't have made it out of there. I guess that's one time that made me happy to have diabetes. And I think that saved us,” said Delp.     Now, he still checks his blood sugar daily but trusts his hands more than high-tech insulin pumps.   “I'm not satisfied with the sensors they have today. I just don't think they're accurate.”   To many, Bob's survival is extraordinary. To him, it's luck.   “The genes are there already, I can't change that so I guess I would have to say just lots of good luck,” said Delp.     And through it all, optimism has been his compass.   “You might fumble the ball, but if you're determined to be a winner, you'll recover that fumble someday,” said Delp.   He still welds nearly every day. Not because he has to, but because it keeps him going.   “As long as I keep doing something like this, I will not be in the nursing home,” said Delp.   https://www.kfyrtv.com/2025/08/09/against-all-odds-montana-man-thrives-with-type-1-diabetes-90/ XX Today, Dexcom is building on this belief and breaking new ground with the launch of its first open call across the U.S. and Canada in search of the next diabetes advocates—giving people with all types of diabetes a once-in-a-lifetime opportunity to raise awareness and share their voice on a global scale in the company's World Diabetes Day campaign (Nov. 14) and beyond.  Who is eligible?: Anyone age 2+ living with all types of diabetes or prediabetes can be nominated by themselves or by someone who knows them. Selected candidates will embody strength, advocacy and pride in living with diabetes or prediabetes. Where and how can I nominate myself or someone I know?: Visit Dexcom.com/WorldDiabetesDay When is the deadline to submit a nomination?: Nominations are open from September 10 through September 19 at 12pm PT. What will the selected candidates experience?:   An invite to participate in a World Diabetes Day photoshoot in Los Angeles to have their unique story featured in Dexcom's World Diabetes Day campaign The ongoing opportunity to attend events, connect with community, and raise diabetes awareness around the world XX The European Association for the Study of Diabetes (EASD) 2025 Annual Meeting will feature major clinical trial results in type 2 diabetes (T2D), type 1 diabetes (T1D), obesity, several new clinical practice guidelines, and much more. The 61st annual EASD meeting will take place on September 15-19, 2025, in Vienna, Austria.   

Why Writing a Book in 2025 Is a Game-Changer for Entrepreneurs: Expert Insights from Book Coach Jennifer CrosswhiteIn today's fast-moving business world, standing out as a thought leader requires more than just expertise—it requires authority. In this episode of The Thoughtful Entrepreneur, host Josh Elledge sits down with Jennifer Crosswhite, seasoned book coach, editor, and CEO and Owner of Tandem Services Inc., to discuss why writing a book in 2025 is one of the most powerful moves an entrepreneur, coach, or CEO can make. Jennifer shares her experience navigating both traditional and self-publishing, revealing actionable strategies for turning your ideas into a book that builds credibility, influence, and lasting impact.Why a Book is Your Ultimate Authority ToolWriting a book in 2025 is not just about putting words on a page—it's about creating a strategic asset that can transform your business and personal brand. Jennifer emphasizes that a book functions as a tangible symbol of authority, often called a “$10 business card,” and provides a global platform for your message. Beyond credibility, books open doors to speaking engagements, media appearances, consulting opportunities, and strategic partnerships that would otherwise be out of reach.Another important point Jennifer makes is that publishing today is democratized. With self-publishing, hybrid models, and AI tools, entrepreneurs now have unprecedented access to producing high-quality content while directly connecting with their audience. AI can help with research, outlining, and drafting—but the unique voice and expertise of the author remain irreplaceable.Finally, a book is not about filling pages—it's about transformation. Jennifer stresses the importance of curating ideas, reverse-engineering your content for impact, and keeping your audience's journey front and center. When done strategically, a book becomes a tool to guide, inspire, and educate readers, creating measurable business growth and influence.About Jennifer CrosswhiteJennifer Crosswhite is a seasoned book coach, editor, and CEO and Owner of Tandem Services Inc., with extensive experience in traditional publishing, self-publishing, and coaching first-time authors. She helps entrepreneurs, thought leaders, and business owners craft books that establish authority, attract opportunities, and create lasting impact for readers and their businesses.About Tandem Services Inc.Tandem Services Inc. is a full-service coaching and publishing company dedicated to guiding authors from concept to published work. From strategic planning and outlining to editing and coaching, Tandem Services empowers business leaders to write books that not only position them as experts but also open doors to new opportunities, audiences, and revenue streams.Links Mentioned in this EpisodeTandem Services Inc. WebsiteJennifer Crosswhite on LinkedInKey Episode HighlightsWhy writing a book is the ultimate authority and credibility builder in 2025.How self-publishing and AI tools are changing the modern publishing landscape.Common misconceptions about book writing: it's not about page count, it's about transformation.Jennifer's two-step brainstorming process: brain dump and organization for maximum impact.The benefits of working with a book coach: accountability, expert feedback, and positioning your book for success.ConclusionWriting a book in 2025 is more than a creative project—it's a strategic business move that can set you apart, build authority, and expand your reach globally. Jennifer Crosswhite's...

Wir sprechen über Aerodynamik beim Radfahren. Diesmal im Fokus mit Jens Klötzer: Der Mensch auf dem Fahrrad. (00:00:00) Begrüßung (00:03:44) Wie aerodynamisch ist ein Mensch? (00:04:56) Warum messt ihr mit halben Menschen? (00:05:54) Was macht uns zu Bremsern? (00:08:04) Vergleich zum Schwimmen (00:10:01) Welche Vergleichswerte bieten sich an? (00:11:42) Wie lässt sich Aerodynamik optimieren? (00:13:18) Einfache Justierungen verändern viel (00:13:36) Sitzposition wirksamer als Sattelstütze (00:15:05) Wie wirken Stoffe? (00:19:13) Der Helm (00:20:47) Rasierte Beine und aerodynamische Socken (00:24:38) Windschatten im Peloton (00:27:43) Windschattenfahren – Vorteil für beide (00:29:43) Körperhaltung (00:36:42) Was können Nicht-Profis davon mitnehmen? (00:40:46) The Beths – Straight Line Was A Lie Coverfoto: Julien de Rosa / AFP Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about WERBUNG Kloster Kitchen unterstützt euch Stück für Stück dabei, euer Wohlbefinden und eure Lebensqualität auf einfache und natürliche Weise zu verbessern. Für einen bewussten Lebensstil – Inspiriert von traditionellem Wissen und modernen Bedürfnissen. Mit dem Code ANTRITT15 erhaltet ihr 15% Rabatt auf alle Produkte (ausgenommen Abos und Gutscheine) auf www.klosterkitchen.de. Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-lufti-aerodynamik-am-menschen-auf-dem-fahrrad

Wir sprechen über Aerodynamik beim Radfahren. Diesmal im Fokus mit Jens Klötzer: Der Mensch auf dem Fahrrad. (00:00:00) Begrüßung (00:03:44) Wie aerodynamisch ist ein Mensch? (00:04:56) Warum messt ihr mit halben Menschen? (00:05:54) Was macht uns zu Bremsern? (00:08:04) Vergleich zum Schwimmen (00:10:01) Welche Vergleichswerte bieten sich an? (00:11:42) Wie lässt sich Aerodynamik optimieren? (00:13:18) Einfache Justierungen verändern viel (00:13:36) Sitzposition wirksamer als Sattelstütze (00:15:05) Wie wirken Stoffe? (00:19:13) Der Helm (00:20:47) Rasierte Beine und aerodynamische Socken (00:24:38) Windschatten im Peloton (00:27:43) Windschattenfahren – Vorteil für beide (00:29:43) Körperhaltung (00:36:42) Was können Nicht-Profis davon mitnehmen? (00:40:46) The Beths – Straight Line Was A Lie Coverfoto: Julien de Rosa / AFP Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about WERBUNG Kloster Kitchen unterstützt euch Stück für Stück dabei, euer Wohlbefinden und eure Lebensqualität auf einfache und natürliche Weise zu verbessern. Für einen bewussten Lebensstil – Inspiriert von traditionellem Wissen und modernen Bedürfnissen. Mit dem Code ANTRITT15 erhaltet ihr 15% Rabatt auf alle Produkte (ausgenommen Abos und Gutscheine) auf www.klosterkitchen.de. Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-lufti-aerodynamik-am-menschen-auf-dem-fahrrad

Ecoutez RTL Soir avec Anne-Sophie Lapix du 11 septembre 2025.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

Zweistelliges Wachstum im Vertrieb – wie geht das in einem schwierigen Marktumfeld? Genau das gelingt Schäferbarthold, einem traditionsreichen Kfz-Teile-Großhändler. Im Gespräch mit Michael Möhrer, Vertriebsleiter bei Schäferbarthold, erfährst du, welches besondere Vertriebskonzept hinter diesem Erfolg steckt und warum es gerade in Zeiten des Umbruchs funktioniert. Stell dir vor, du bist in einer Branche unterwegs, die stark vom Wettbewerb geprägt ist und in der Margen und Kundenbeziehungen über alles entscheiden. Genau hier zeigt Schäferbarthold, dass nachhaltiges Wachstum im Vertrieb möglich ist – mit einer klaren Strategie, die sowohl auf persönliche Kundenbindung als auch auf ein innovatives Vertriebsmodell setzt. Ein Kernelement für das zweistellige Wachstum im Vertrieb ist das hybride Vertriebsmodell: Innen- und Außendienst arbeiten eng im Tandem zusammen. Während der Außendienst den persönlichen Kontakt zu den Kunden pflegt, übernimmt der Innendienst die tägliche Betreuung und schnelle Reaktionszeiten. Dieses Modell sorgt für Verlässlichkeit, Nähe und gleichzeitig Effizienz im Vertrieb. Das Besondere: Beide Rollen werden gleichwertig behandelt – ein klarer Unterschied zu vielen Mitbewerbern. Auch das Vergütungssystem ist einzigartig. Schäferbarthold setzt nicht mehr ausschließlich auf klassische Provisionsmodelle, sondern auf individuelle Zielvereinbarungen. So können neue Produktlinien gezielt gefördert und Mitarbeiter flexibel gesteuert werden. Das schafft Motivation und Klarheit – und fördert gleichzeitig gesunden Wettbewerb innerhalb des Teams. Ein weiterer Erfolgsfaktor für das zweistellige Wachstum im Vertrieb: persönliche Beziehungen. Während viele Unternehmen Angst haben, dass zu enge Bindungen zwischen Verkäufer und Kunde ein Risiko darstellen, sieht Schäferbarthold darin einen klaren Wettbewerbsvorteil. „Ich kaufe bei Manni“ ist hier keine Schwäche, sondern ein Beweis für Vertrauen und Verlässlichkeit. Die starke Bindung der Mitarbeiter ans Unternehmen sorgt zudem dafür, dass Kunden auch langfristig treu bleiben. Dazu kommt eine besondere Rolle im Vertrieb: der „Außendienstleiter“. Er ist kein klassischer Vorgesetzter mit disziplinarischer Macht, sondern ein Coach und Trainer, der Wissen weitergibt und neue Mitarbeiter begleitet. Dieses Modell fördert Wissenstransfer, Motivation und eine starke Vertriebskultur. Im Podcast sprechen wir auch über die Zukunft der Branche. Elektrofahrzeuge, alternde Fahrzeugbestände und eine zunehmende Konsolidierung im Aftermarket stellen Herausforderungen dar – gleichzeitig ergeben sich Chancen für Unternehmen, die flexibel und kundennah agieren. Schäferbarthold ist hier bestens aufgestellt und wächst seit Jahren zweistellig. Wenn du lernen willst, wie auch dein Unternehmen zweistelliges Wachstum im Vertrieb erreichen kann, dann solltest du in diese Episode unbedingt reinhören!  

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

In this episode of Thriving in Tandem, Robert and Kay Lee unpack the dangers of making impulsive business or investment decisions based on hype, emotion, or pressure. Whether it's a flashy marketing strategy, a “can't miss” real estate deal, or a new business venture, many married entrepreneurs get swept up in the excitement without counting the cost. Drawing from real-life lessons—some painful—they discuss how couples can safeguard their finances and their marriage by slowing down, asking the right questions, and aligning their risk tolerance. Together, they walk through key decision-making pitfalls: FOMO, emotional buying, and lack of due diligence. You'll learn how to avoid being manipulated by urgency or scarcity tactics and how to test business ideas in small ways before investing big. Most importantly, Robert and Kay Lee show how couples can communicate through their differences in risk tolerance and move forward in unity—because your business should grow your wealth, not blow up your relationship. Want to live a better balanced life and win in marriage AND business at the same time? Purchase our (audio) book Tandem: The married entrepreneurs' guide for greater work-life balance. https://www.thetandembook.com/ Download the 5 Daily Habits to Thrive in Tandem https://marriedentrepreneur.co/5-daily-habits-download  Need some insight into how to balance it all? Schedule a free discovery call. https://marriedentrepreneur.co/lets-talk Key Takeaways: Risk tolerance matters—especially in marriage. Know yours, know your spouse's, and talk about it before you're faced with a big decision. Don't let hype override wisdom. Watch out for pressure tactics like limited-time offers or guaranteed returns—they're red flags. Test before you invest. Whether it's marketing or real estate, start small. Use low-cost or no-cost methods to gauge results first. Emotions + speed = danger. Fast decisions made under emotional pressure are more likely to backfire. Take time to assess the risk. Do your due diligence. Ask hard questions. Get wise counsel. Research independently. Don't rely solely on what a salesperson says.

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

#Engelsiz

Wiebke ist mit dem Rad von Paris nach Hause gefahren — nach dem Krebs. Hedwig war bei der Deutschlandtour und Gerolf in Frankreich. (00:00:00) Begrüßung nach dem Urlaub und Rückblick auf August (00:04:07) Ausblick auf die Folge (00:04:54) Mit dem Fahrrad nach Paris – Wovon hat Wiebke geträumt? (00:06:50) Warum Paris? (00:07:43) Die Krankheitsgeschichte (00:11:31) Angepasste Ausstattung (00:12:58) Die Entscheidung: Let's go (00:15:04) Warum in Gegenrichtung? (00:15:47) Welche Räder? (00:17:01) Tourroute (00:20:49) Der schönste Moment (00:27:22) Reflexion und the Power of Radfahren (00:30:04) Hedwig – Kinderrennen zur Deutschlandtour (00:31:36) Warum hat Hedwig mitgemacht? (00:32:54) Der Streckenverlauf (00:34:36) Deutschlandtour quasi durch den Garten (00:35:33) Der schönste Moment (00:37:11) Nachgespräch Hedwig (00:38:50) Gerolf empfiehlt die Pyrenäen (01:01:44) Musik: Rival Schools – Good Things Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about WERBUNG Kloster Kitchen unterstützt euch Stück für Stück dabei, euer Wohlbefinden und eure Lebensqualität auf einfache und natürliche Weise zu verbessern. Für einen bewussten Lebensstil – Inspiriert von traditionellem Wissen und modernen Bedürfnissen. Mit dem Code ANTRITT15 erhaltet ihr 15% Rabatt auf alle Produkte (ausgenommen Abos und Gutscheine) auf www.klosterkitchen.de. Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt >> Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-wiebke-nach-dem-krebs-hedwig-bei-der-deutschlandtour-gerolf-unterwegs

Due voci, una sola direzione: il divertimento!Michael Casanova e Danny Morandi tornano insieme su Radio 3i per accompagnarti in un viaggio fatto di risate, musica e tanta energia. Dal lunedì al giovedì dalle 16 alle 18 e il venerdì dalle 15 alle 18, sali anche tu sul nostro tandem radiofonico: una pedalata a due che diventa un giro infinito di emozioni grazie agli ascoltatori, veri compagni di avventura!

In this special live-audience episode of Thriving in Tandem, Robert and Kay Lee welcome back long-time friends and returning guests, Jim and Martha Brangenberg. From running a real estate development project to revitalizing their small town, serving as volunteer firefighters and chaplains, caring for aging parents, hosting their radio show I Work for Him, and spearheading community events — Jim and Martha live a full, fast-paced life. Yet, despite the chaos, they've learned the value of slowing down, setting boundaries, and keeping God at the center of their marriage. Together, we unpack the disciplines, decisions, and daily habits that help them work as a team in both life and business. They share how prayer has been their “secret sauce” for 43 years, why listening to each other's God-given instincts matters, and how choosing connection over conflict has kept their relationship strong. From avoiding “hangry” arguments to navigating seasons where traditional date nights are impossible, Jim and Martha offer practical, real-life strategies for staying close in the busiest of seasons. Whether you're building a business, leading in your community, or simply juggling the everyday demands of marriage and family, this episode will encourage you to protect your partnership, prioritize your quiet time with God, and let go of the small stuff that doesn't matter in the long run. Jim and Martha's story is a reminder that thriving in tandem isn't about perfection — it's about intention, grace, and staying on the same team no matter what. Listen to them on https://www.iwork4him.com/  Listen to episode 82 https://marriedentrepreneur.co/blog/dance-business-spous https://www.iwork4him.com/  Key Takeaways: Prayer is a powerful anchor — begin and end your day with it, even if everything else falls apart. Listen to and respect your spouse's instincts, especially when they feel prompted by God. Protect your marriage from unnecessary tension by “letting go” of minor irritations. Seasons of busyness may require redefining date nights — connection matters more than formality. Set boundaries with your time, use your calendar intentionally, and be willing to say no to protect your priorities. True teamwork means surrendering your agenda to God's direction and committing to run the race together. Bio: Jim Brangenberg An entrepreneur for life, Jim has grown several start-ups and mentored many business owners. His God-gifted ability to ask the right questions lends itself well to his role as host of the iWork4Him program, the Faith and Work mouthpiece founded in 2013. Martha Brangenberg Born into an entrepreneurial family, Martha has been involved in small business her entire life. Gifted with an attention to detail and a sweet sensitive spirit, Martha is a servant leader with a deep faith in Jesus. Together, Jim and Martha are passionate about living out faith at work, building strong marriages and regularly offer marriage retreats. They have three grown children and six grandchildren. Want to live a better balanced life and win in marriage AND business at the same time? Purchase our (audio) book Tandem: The married entrepreneurs' guide for greater work-life balance. https://www.thetandembook.com/ Download the 5 Daily Habits to Thrive in Tandem https://marriedentrepreneur.co/5-daily-habits-download  Need some insight into how to balance it all? Schedule a free discovery call. https://marriedentrepreneur.co/lets-talk  

2 ans après Toni en famille, Nathan Ambrosioni, 26 ans, retrouve l'actrice Camille Cottin pour un nouveau film ensemble : Les enfants vont bien.Les Enfants vont bien a décroché ce week-end la plus haute récompense du Festival du film francophone d'Angoulême, le Valois de Diamant. Il y était présenté en avant-première et en compétition, avant sa sortie le 3 décembre 2025.Pour en savoir plus sur ce film très attendu, nous vous proposons de découvrir dès à présent notre échange avec le tandem Camille Cottin et Nathan Ambrosioni, enregistré au Festival d'Angoulême.Toni en famille, sorti en septembre 2023, a fait plus de 300 000 entrées et était une des jolies surprises de cette année. Il a connu un joli succès en salles, public et critique(avec une note Allociné de 3,9 côté presse, et 3,8 côté spectateurs).CréditsJournaliste : Brigitte BaronnetMontage : Constance Mathews Hébergé par Audion. Visitez https://www.audion.fm/fr/privacy-policy pour plus d'informations.

In this episode, we're joined by Lukas Saari, CEO and Co-Founder of Tandem Health, the AI-driven platform transforming how clinicians and healthcare teams work together to deliver better patient outcomes. By combining customer obsession with advanced automation, Tandem Health empowers providers to streamline workflows, reduce administrative burden, and keep the human touch at the center of care. We spoke with Lukas about how AI is reshaping one of the most traditional industries and how Tandem Health has built trust with customers by deeply understanding their real-world pain points. Here are some of the key questions we address: How do you build trust with customers in industries where credibility and experience matter most? Why should commercial and product teams include people who've actually lived their customers' pain points? How does every new onboarding experience fuel product innovation? What role does deep customer understanding play in deciding where to take the product next? Why must SaaS founders think in terms of “jobs to be done” rather than features, and how does that mindset unlock customer value?

John Clark is the founder of Modern Shelving and Tandm Surf, two brands born from a simple idea: if he could sell it, his wife, an engineer, could build it. What started as a family-run shelving business evolved into a global Ecommerce company, while a day on the water with his daughter inspired an inflatable tandem surfboard that would later appear on Shark Tank.John's journey blends practicality with creativity. From solving everyday pain points with shelving to creating a patented surfboard that makes riding waves accessible to anyone, he's built businesses that reflect both lifestyle and innovation. Along the way, he's navigated the challenges of pitching on national TV, scaling niche products in the DTC market, and balancing multiple ventures without losing his entrepreneurial spark.Whether you're running a growing ecommerce brand or looking to turn family values into scalable business, John offers an honest look at what it takes to transform passion into products people love and companies that last.In This Conversation We Discuss:[00:37] Intro[01:21] Launching new products to fuel business growth[03:14] Adopting Google Adwords to drive early sales[04:00] Turning family traditions into a business idea[05:39] Making surfing accessible to everyone[07:07] Sharing prototypes at the beach for feedback[08:00] Pitching novelty ideas that capture attention[09:28] Episode Sponsors: Electric Eye, Heatmap, Grow[12:40] Answering what really happens after the deal[14:29] Leveraging the Shark Tank bump for growth[17:56] Using events to build brand visibility[19:06] Finding the right partner for long-term success[19:40] Patenting inflatable boards for portability[20:45] Building community beyond physical products[23:01] Encouraging entrepreneurs to think globallyResources:Subscribe to Honest Ecommerce on YoutubeVersatile designs + unique storage solutions for any space modernshelving.com/Shark Tark approved Tandem bodyboards and pool saddles tandmsurf.com/Follow John Clark linkedin.com/in/johngclarkSchedule an intro call with one of our experts electriceye.io/connectClear, real-time data built for ecommerce optimization heatmap.com/honestThe Premier Conference for Ecommerce Operators joingrow.comIf you're enjoying the show, we'd love it if you left Honest Ecommerce a review on Apple Podcasts. It makes a huge impact on the success of the podcast, and we love reading every one of your reviews!

Join Robert and Kay Lee Fukui as they draw surprising yet powerful parallels between crafting a fine bottle of wine and building a strong, lasting marriage. Fresh off their dream vacation to Italy and inspired by the care, patience, and intentionality they witnessed at the wineries, the Fukuis unpack four key principles that apply both to wine-making and thriving in tandem with your spouse: patience, environment, oxygen (aka communication and emotional safety), and blend. Through personal stories—from the early days of their relationship to navigating conflict and collaboration in business—they share how patience creates room for growth, how cultivating the right environment fosters trust, how healthy communication lets go of toxic buildup, and how honoring each other's differences creates the perfect blend in marriage and business. Whether you're a wine lover or just looking for a fresh way to strengthen your relationship, this episode will challenge and encourage you to be more intentional in your marriage and business. Want to live a better balanced life and win in marriage AND business at the same time? Purchase our (audio) book Tandem: The married entrepreneurs' guide for greater work-life balance. https://www.thetandembook.com/ Download the 5 Daily Habits to Thrive in Tandem https://marriedentrepreneur.co/5-daily-habits-download  Need some insight into how to balance it all? Schedule a free discovery call. https://marriedentrepreneur.co/lets-talk Key Takeaways: Patience pays off: Just like wine matures under the right conditions, great marriages require time, grace, and room to process emotions and decisions. Environment matters: Creating a safe, supportive space—both emotionally and physically—allows your spouse (and your team) to thrive. Let it breathe: Addressing conflict and giving each other space to communicate reduces relational toxicity and builds emotional intimacy. Blended is better: Embrace your spouse's strengths, differences, and gifts—together, you're far more powerful and approachable as a team.

Tandem has built an impressive portfolio scaling from single-family homes to a 200-unit high-rise in Chicago's competitive market. To explain why Crain's took notice with a recent article about the firm, co-founders Tony Andrews and Dimitri Nassis share their remarkable journey with host Phil Coover. After reconnecting in an airport, the childhood friends partnered on their first profitable single-family project. “It was just very simple for me,” Tony recalls. “The accounting was simple. It's pluses and minuses and a little bit of division.” The duo expanded into multifamily developments, weathering the recession of ‘08 and Covid shut-downs. Tune in for their insights about vertical integration in development, the hidden profit strategies some general contractors use, and prioritizing transparency over traditional bidding battles. Connect and Learn More☑️ Dimitri Nassis | LinkedIn☑️ Tony Andrews | LinkedIn☑️ Tandem | LinkedIn | Facebook | YouTube☑️ Phil Coover | LinkedIn☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X☑️ Subscribe Apple Podcasts | Spotify | Amazon MusicThis podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed...

 It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: cancer reserach may lead to T1D treatment, GLP-1 oral pill moves forward, Tandem pharmacy moves, Medtronic-Abbott sensor unveield, parents of kids with T1D see income drop, Mannkind submits Afrezza for pediatrics, diabetes scholarships and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Cornell researchers have developed an implant system that can treat type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, without the need for immunosuppression. The system could also potentially provide long-term treatment for a range of chronic diseases. This lab has produced previous implantable devices that have proved effective in controlling blood sugar in diabetic mice, but they can only last so long. "It's the proof of concept. We really proved that oxygenation is important, and oxygenation will support high cell-density capsules," Tempelman said. "The capsules are immune protective and last for a long time without having some kind of fouling of the membrane. The body never likes it when you put a foreign substance in. So that's the engineering in the Ma Lab, to look for materials and coatings for the materials that are immune protective, but also don't invoke excess response from the body because of the material." The next step will be to implant the system in a pig model, and also test it with human stem cells. The researchers are interested in eventually trying to use the system for implanting different cell types in humans for long-term treatment of chronic diseases, according to Tempelman, who is CEO of Persista Bio Inc., a new startup she founded with Ma and Flanders that is licensing these technologies. https://medicalxpress.com/news/2025-08-implant-diabetes-oxygenating-insulin-cells.html XX Mayo Clinic cancer research may be big news for T1D. After identifying a sugar molecule that cancer cells use on their surfaces to hide from the immune system, the researchers have found the same molecule may eventually help in the treatment of type 1. Cancer cells use a variety of methods to evade immune response, including coating themselves in a sugar molecule known as sialic acid. The researchers found in a preclinical model of type 1 diabetes that it's possible to dress up beta cells with the same sugar molecule, enabling the immune system to tolerate the cells. The findings show that it's possible to engineer beta cells that do not prompt an immune response   In the preclinical models, the team found that the engineered cells were 90% effective in preventing the development of type 1 diabetes. The beta cells that are typically destroyed by the immune system in type 1 diabetes were preserved.     https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-find-sugar-coating-cells-can-protect-those-typically-destroyed-in-type-1-diabetes/ XX A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a clinical trial announced by Eli Lilly on Thursday morning.   The drug, orforglipron, is a GLP-1, a class of drugs that have become blockbusters because of their weight-loss effects. But the GLP-1s on the market now are expensive, must be kept refrigerated and must be injected. A pill that produces similar results has the potential to become far more widely used, though it is also expected to be expensive.   Lilly said it would seek approval from the Food and Drug Administration later this year to market orforglipron for obesity and early in 2026 for diabetes. https://www.nytimes.com/2025/04/17/health/pill-glp-1-eli-lilly.html XX Use of diabetes technology has dramatically increased and glycemic control has improved among people with type 1 diabetes (T1D) in the US over the past 15 years, but at the same time, overall achievement of an A1c level < 7% remains low and socioeconomic and racial disparities have widened. These findings came from an analysis of national electronic health records of nearly 200,000 children and adults with T1D by Michael Fang, PhD, of the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues. The study was published online on August 11, 2025, in JAMA Network Open. Use of continuous glucose monitors (CGMs) increased substantially from 2009-2011 to 2021-2023, from less than 5% in both children and adults to more than 80% and over half, respectively. While A1c levels did drop over the 15 years, just 1 in 5 children and slightly over a quarter of adults achieved a level < 7%. The average A1c level stayed above 8%, with ethnic minorities and low-income patients seeing the smallest gains.       https://www.medscape.com/viewarticle/diabetes-tech-use-rise-a1c-reductions-still-lag-2025a1000lc9 XX Inflammation may predict how well people with diabetes respond to depression treatment, and the effects differ dramatically between type 1 and type 2 diabetes. Diabetes and depression often appear together. Indeed, depression is more than three times more prevalent in people with type 1 diabetes (T1D) and nearly twice as prevalent in people with type 2 diabetes (T2D). When they appear together, treatment for depression can vary widely. In a new study, researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim (FIDAM), and the German Center for Diabetes Research (DZD) investigated how inflammation in the body relates to improvement in depression symptoms in people with T1D and T2D. The researchers combined data from three previous German randomized clinical trials that aimed to reduce elevated depressive symptoms and diabetes distress in people with type 1 or type 2 diabetes. Diabetes distress is characterized by feelings of overwhelm, frustration, guilt and worry about diabetes management and its potential complications. A total of 332 participants with T1D and 189 with T2D who had completed both a baseline and 12-month follow-up examination were included in the present study. Measures included depression using the Center for Epidemiological Studies Depression scale (CES-D), blood tests for 76 inflammatory biomarkers, and symptoms broken down into cognitive-affective (e.g., feeling hopeless), somatic (e.g., poor sleep, fatigue), and anhedonia (loss of pleasure) clusters.   After adjusting for factors like age, body mass index (BMI), diabetes duration, cholesterol, and co-existing illnesses, the researchers found that in patients with T1D, higher baseline inflammation was linked to smaller improvements in depression. Inflammation seemed to be more connected to physical/somatic symptoms in T1D patients. In those with T2D, higher baseline inflammation was linked to greater improvements in depression. For these patients, the effect was strongest for cognitive-affective and anhedonia – so, emotional and motivational – symptoms.   The researchers weren't sure what caused the difference between T1D and T2D, but they suggest it might be due to the different forms of immune activation seen in each condition. That is, autoimmune processes in type 1 and metabolic inflammation in type 2. https://newatlas.com/health-wellbeing/inflammation-diabetes-depression-treatment/ XX Parents of children diagnosed with type 1 diabetes suffer an income drop in the years following the diagnosis. The impact is more pronounced in mothers, especially mothers of children diagnosed in preschool years. And these findings come from a European study.. not the US. Previous research has shown that parents of children with type 1 diabetes are at increased risk of stress-related symptoms and may need to reduce their working hours. "In our study, we observed reduced parental work-related incomes in the years following the child's type 1 diabetes diagnosis. The drop was larger in mothers than in fathers. Since mothers earned significantly less than fathers in absolute terms, even before the child fell ill, the relative drop in mothers was 6.6% the year following diagnosis compared to 1.5% in fathers. We further note the greatest impact on work-related incomes in mothers of children diagnosed at preschool age," says Beatrice Kennedy, physician at the Endocrine and Diabetes unit at Uppsala University Hospital and Associate Professor of Medical Epidemiology at Uppsala University, who led the study. This is a huge study, builds on data from national population and health registers and the Swedish Child Diabetes Register (Swediabkids). The study includes the parents of more than 13,000 children diagnosed with type 1 diabetes in Sweden in 1993−2014, as well as more than half a million parents in the general population who have children not diagnosed with diabetes.   The researchers observed that the maternal pension-qualifying incomes (a composite outcome including work-related income and societal benefits) initially increased after the child's diagnosis. This was attributable to mothers applying for the parental care allowance from the Swedish Social Insurance Agency. The parental care allowance was intended to compensate for disease-related loss of work-related income and contribute toward disease-specific costs.   When the research team investigated long-term effects in mothers, they found that the pension-qualifying incomes gradually decreased after eight years, and had not recovered by the end of follow-up − 17 years after the children were diagnosed. https://www.news-medical.net/news/20250811/Mothers-face-greater-financial-impact-following-childe28099s-type-1-diabetes-diagnosis.aspx XX The U.S. Department of Justice has reached a settlement with Metro Nashville Public Schools after allegations that the district violated the Americans with Disabilities Act.   The parents of a student at the Ross Early Learning Center requested that the school monitor their child's glucose monitor. Investigators found the school refused to do so, despite the child's Type 1 Diabetes diagnosis.   As part of the settlement, MNPS agreed to change its policies to allow the use of these devices, ensure trained staff can monitor them throughout the entire school day and at school activities, and improve communication with parents. https://www.wsmv.com/2025/08/12/metro-nashville-public-schools-settles-allegations-it-discriminated-against-students-with-diabetes/ XX Modular Medical has unveiled Pivot, its next-generation insulin patch pump technology aimed at simplifying diabetes care. The company announced its new pump for “almost-pumpers” at the Association of Diabetes Care & Education Specialists (“ADCES”) Conference in Phoenix, Arizona this weekend. It aims for Pivot to target adults with a user-friendly, affordable design.   Modular Medical's current pump, the MODD1, won FDA clearance nearly a year ago. It features new microfluidics technology to allow for the low-cost pumping of insulin. The system has a reservoir size of 300 units/3mL. Users can monitor the pump activity with their cell phone and do not require an external controller. The pump uses a provided, single-use, disposable battery.   The company announced recently that it validated its insulin pump cartridge line for human-use production in the U.S. Days later, it reported the first human use of the MODD1 pump.   Now, it has taken the next steps with the debut of a next-gen pump, set for FDA submission in October.   Modular Medical also gamifies diabetes care The company also said ADCES is the place where it will showcase the first playable level of its new Pivot pump gamified trainin module. Level Ex, a developer of medical games, develops the module.   Modular Medical said gamification offers a way to make medical training more effective and efficient while improving information retention. Given the complexity in pump uptake, the company hopes to provide an easy way to bring its technology to clinicians and patients.   The company expects to have training modules available at the same time as the pump's planned launch in 2026.   “Level One is free because diabetes mastery shouldn't come with a price tag,” Sam Glassenberg, CEO of Level Ex, said. “Modular Medical is breaking barriers too – bringing pump therapy to more people through smart, accessible design. Together, we intend to make diabetes management simpler and more inclusive.   “People learn best through play – and we believe they want to learn about insulin pumps the same way. In Level One, players aren't just mastering diabetes management through gameplay – they're asking to ‘play' with pumps: to explore how they work, understand their benefits, and build confidence before using them in real life. Our partnership with Modular Medical helps make that possible.” https://www.drugdeliverybusiness.com/modular-medical-unveils-next-gen-insulin-pump/ XX On Tuesday, 12 August 2025, Tandem Diabetes Care (NASDAQ:TNDM) presented at the Canaccord Genuity's 45th Annual Growth Conference, outlining strategic shifts and market focus. The company highlighted its plans for commercial transformation in the U.S. and expansion in international markets, alongside addressing competitive challenges and regulatory impacts. While optimistic about growth in Outside the U.S. (OUS) markets, Tandem is navigating a more competitive landscape domestically. We have entered into the pharmacy channel with Mobi only. And so as Mobi's been building up volume, we're getting experience and we're really learning and understanding what pharmacy offers to us. And the proof points have proved out the thesis I said earlier, which is it can really reduce that barrier for patients, is the out of pocket cost. And so we've decided to accelerate our strategy and where we were starting just with Mobi, we are now moving t slim supplies into the pharmacy channel, and that will kick into gear in the fourth quarter. So as people are looking at the cadence of sales for the remainder of the year with this reframing, many folks are seeing what looks like a a might be an outsized fourth quarter and and having trouble understanding those dynamics. We'll be adding the tSIM supplies to those contracts. We also have more coverage. We will have it in the coming weeks effective this year, so we will be increasing that 30% rate before the end of the year. And then, obviously, everyone's in the same cycle right now already negotiating and discussing their 2026 coverage. And so 30% is the floor.   We do expect to continue to grow that coverage in the coming years, and ultimately have a much broader access. Absolutely. It's an exciting technology that allows for us to have an infusion set that extends the wear time from three days to up to seven days. So we're able to use that as part of an independent infusion set, which would then be used with the t slim and with the mobi pump today. But we're also using that same technology as part of the site that's used for mobi when you use it with a tubeless cartridge. So next year, we will launch Mobi in a patch configuration.   It uses the same pump that's available today, but by using a modified cartridge, you're able to wear it as a patch pump. So one of the things we announced on the call is that we're using this extended wear technology as part of that site. So what it allows you to do is to change the portion that you wear in your skin separate from the timing of when you change the insulin cartridge. So it allows for that extended wear time, reduction of burden to the patient, which is especially important for higher volume insulin users as we expand into type two. So from here, we will launch the extended wear site next year along with we'll do a separate regulatory filing for the cartridge portion for Mobi that includes this extended wear technology as a predicate device. So that's another filing that we'll need to do, but we have the clearance today for the independent infusion set, but we'll file another five ten k for use of the extended wear technology as part of the tubeless Mobi feature. https://za.investing.com/news/transcripts/tandem-diabetes-at-canaccord-conference-strategic-shifts-and-market-focus-93CH-3834464 XX MannKind today announced a significant regulatory submission and a large financing agreement with Blackstone. The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said.   First, the Danbury, Connecticut-based company announced that it submitted a supplemental Biologics License Application (sBLA) for Afrezza, its inhaled insulin product, in the pediatric population.   MannKind Director of Medical and Scientific Engagement Joanne Rinker, MS, RDN, BC-ADM, CDCES, LDN, FADCES, told Drug Delivery Business News at ADA 2025 that a submission was on the way for children and adolescents aged 4-17 years old. Further data shared at ADA found Afrezza both safe and effective in that age range.   Afrezza is a fast-acting insulin formulation delivered through an inhaler device. MannKind engineered the mechanical inhaler device to slowly bring powder into the lung. A small compartment opens for the insertion of the insulin cartridge, then the user closes it. The only other component is a mouthpiece for the sake of cleanliness. Then, the inhalation takes just two seconds. It requires no electronics or extra components.   The company expects a review acceptance decision early in the fourth quarter of 2025.   “The submission of our supplemental Biologics License Application (sBLA) for Afrezza in pediatric patients is a meaningful milestone for MannKind and people living with diabetes,” said Michael Castagna, CEO of MannKind Corporation.   Additional funding provides a significant boost for MannKind MannKind also announced a strategic financing agreement with funds managed by Blackstone worth up to $500 million. The financing provides MannKind with non-dilutive capital to advance its short- and long-term growth strategies.   This senior secured credit facility includes a $75 million initial term loan funded at closing. It then has a $125 million delayed draw term loan available for the next 24 months. Finally, it features an additional $300 million uncommitted delayed draw term loan available at the mutual consent of MannKind and Blackstone.   The facility bears interest at a calculated SOFR variable rate plus 4.75% and matures in August 2030.   “This strategic financing significantly increases our operating flexibility and provides us substantial access to non-dilutive capital on favorable terms, complementing our strong cash position,” said Castagna. “The funding will support the expansion of our commercial team in preparation for the anticipated launch of the pediatric indication for Afrezza, if approved, continued pipeline advancement, potential business development opportunities, and general corporate purposes. Partnering with the Blackstone team on this transaction positions us to accelerate our next phase of growth and innovation.” https://www.drugdeliverybusiness.com/mannkind-fda-submission-pediatrics-500m-blackstone/ XX   Medtronic MiniMed Abbott Instinct Sensor [Image from Medtronic Diabetes on LinkedIn] The Medtronic Diabetes business today took to social media to share an early preview of a new integrated Abbott sensor for its insulin delivery systems. Medtronic Diabetes — soon to be MiniMed after its planned separation from the medtech giant – said in the post that the new sensor specifically designed for its own systems is called “Instinct.”   “Get a sneak peek at what's coming next: the Instinct sensor,” the business unit's account wrote. “Made by Abbott, the Instinct sensor is designed exclusively for MiniMed systems. We'll share more details about the Instinct sensor when it's commercially available.”   The sensor, built on the Abbott FreeStyle Libre platform, reflects “the power of the partnership,” Abbott EVP, Diabetes Care, Chris Scoggins, told Drug Delivery Business News earlier this year.   Medtronic and Abbott — two of the largest diabetes tech companies in the world — announced a year ago that they entered into a global partnership pairing Abbott continuous glucose monitors (CGMs) with Medtronic insulin delivery systems.   The partnership aims to collaborate on a system based on Abbott's FreeStyle Libre CGMs with Medtronic's automated insulin delivery technology (the latest generation being the MiniMed 780G) and smart insulin pen systems, such as the InPen system.   Read more about Medtronic, Abbott and the rest of the diabetes tech industry in our free Diabetes Technology Special Report. Medtronic's systems previously used its own CGMs, such as the Guardian 4 and the Simplera platform, and the company intends to continue using those systems as part of a comprehensive CGM portfolio. Under the companies' agreement, the systems would be sold exclusively by Medtronic — including the Abbott CGM.   The companies brought the partnership a step further in April when Medtronic announced the submission of an interoperable pump with the Abbott sensor technology to the FDA. They plan to share more details following the expected FDA clearance, which remains pending.   Management also recently emphasized the multi-year nature of the partnership, meaning Medtronic could pair current and future pumps with other Abbott sensors in the future. That could hint at integration with the company's future dual glucose-ketone monitor, as a number of pump makers have already announced collaborations to pair their systems with the sensor once it hits the market. https://www.drugdeliverybusiness.com/medtronic-diabetes-previews-abbott-sensor-minimed/ XX Governor Glenn Youngkin joined Civica officials at the company's Petersburg manufacturing facility to announce a $3 million grant from the Commonwealth of Virginia to accelerate Civica's efforts to develop and produce affordable insulin for Americans living with diabetes.   CivicaRx Logo   "We are proud to partner with Civica in their mission to make essential medicines more accessible," said Governor Youngkin. "This investment reflects our belief in the power of public-private collaboration to improve lives and strengthen communities."   These funds will support the production of insulin aspart, a rapid-acting human insulin analog used to regulate blood sugar in adults and children with diabetes. Civica plans to produce both rapid- and long-acting insulins at its state-of-the-art manufacturing facility in Petersburg, Va., where the company now employs more than 200 skilled workers.1 Over 8 million people living with diabetes need rapid-acting and/or long-acting insulin.   The Governor also announced that he had officially proclaimed August 7 – 14 2025 'Life Sciences Week' demonstrating the Commonwealth's commitment to "accelerating the advancement of the life sciences through public-private partnerships, STEM education, workforce development, and sustained investment in research and development."   "We are grateful for the Commonwealth's support," said Ned McCoy, Civica's President and CEO. "This funding will help us move closer toward our goal of ensuring that no one has to choose between insulin and other basic needs."   Civica and Virginia officials were joined by Lynn Starr, Chief Global Advocacy Officer of Breakthrough T1D, the leading global type 1 diabetes research and advocacy organization.   "More than one million American adults live with type 1 diabetes, and many still, sadly, ration their insulin, due to the prohibitively high cost of this necessary medication," said Starr.  "Civica's work will help to make insulin more affordable for people across the country."   Breakthrough T1D is among more than two dozen organizations and philanthropists, along with the states of Virginia and California, that have partnered with Civica to support the development of affordable insulins.   Civica's insulin initiative aims to provide patients with predictable, transparent pricing — no more than $30 per vial or $55 for a box of five pens — regardless of insurance status.   About Civica Civica is a nonprofit pharmaceutical company established to address drug shortages. It was founded by a group of U.S. health systems and philanthropies who, after more than a decade of chronic shortages, recognized that the market was not self-correcting and that a different approach is required. Civica works to deliver a safe, stable, and affordable supply of essential medicines to U.S. patients.   Media Contact: Liz Power liz.power@civicarx.org +1 860 501 3849 https://cbs4indy.com/business/press-releases/cision/20250807NY46213/governor-glenn-youngkin-announces-3-million-grant-to-support-civicas-affordable-insulin-programs/ XX If you or someone you love is living with diabetes, you already know the fight isn't just medical—it's financial, too. Between daily supplies, doctor visits, and long-term care, the cost of managing type 1 or type 2 diabetes can be overwhelming. Add college or trade school into the equation, and suddenly staying healthy competes with building a future. That's where scholarships for students with diabetes—like Beyond Scholars and others listed here—step in.   Whether you're headed to a university, a two-year college, or a hands-on trade program, these opportunities were created to ease the load.   Scholarships for students with diabetes Beyond Scholars (from Beyond Type 1): $10,000 for recently graduated high school seniors with type 1 diabetes or type 2 diabetes entering college or trade school. This is one of the largest needs-based diabetes scholarships in the United States. This year, awardees will also receive 6 months of wellness coaching through Risely Health.   Applications open: July 25, 2025 Deadline: August 29, 2025 Winners announced: October 2025 https://beyondtype1.org/beyond-scholars-diabetes-scholarships-college-trade-school/ XX Nick Jonas and Kyle Rudolph are using their platforms for a good cause.   On Tuesday, Aug. 12, the singer and the former NFL tight end (via his professional fundraising platform Alltroo) announced they're teaming up to launch a rally featuring a fan-coveted prize: a custom 2025 Volkswagen ID. Buzz electric bus that the Jonas Brothers have brought along for their 20th anniversary tour.   “Ten years ago, we hit the road with a goal to change what it means to live with diabetes. Since then, Beyond Type 1 has grown into the world's largest digital diabetes community, offering the tools, education, and peer support needed to not only survive but thrive with diabetes,” Jonas, who co-founded Beyond Type 1 (a nonprofit that advocates for those living with diabetes), says in a statement.     “We've challenged stigma, built community, provided life-saving resources, and collectively driven global innovation toward prevention and cure. This milestone is a moment to rally even more support for our mission, and partnering with Alltroo helps us do that in a powerful, engaging way.”   Related Stories Nick Jonas on Managing His Diabetes: 'The Mental and Emotional Health Aspect Is Really Important' nick jonas Nick Jonas Says He Was Diagnosed with Diabetes After Joe Told Their Parents: 'Something's Really Wrong' Joe Jonas and Nick Jonas attend the amfAR Cannes Gala 30th edition at Hotel du Cap-Eden-Roc on May 23, 2024 For Rudolph, the campaign is about "celebrating Beyond Type 1's incredible work over the past decade, and standing behind their vision of a world where everyone with diabetes — or at risk of it — has access to the knowledge, care and support needed for early diagnosis and lifelong health."   While the rally is live on Alltroo.com, fans can also scan QR codes available at all 36 Jonas Brothers concert stops to enter for a chance to win the electric bus. (A winner will be selected on November 14, which is World Diabetes Day.)   Jonas, 32, has long been open about his Type 1 diabetes diagnosis at 13 years old. "I had this kind of wrench thrown into things when I was diagnosed and it took a while to figure out how to count carbs to properly dose for insulin and what things would affect me in different ways," he previously told PEOPLE.   "When I was first diagnosed, I was sitting in the hospital and was scared to death, honestly, while I was learning about how to manage this new thing I was dealing with," Jonas recalled. "It would have been amazing to have someone to look at at that time to say, oh, this is a person living with it and they're following their dreams. They're doing what they want to do with their lives and not letting it slow them down."           https://people.com/nick-jonas-kyle-rudolph-launch-fan-rally-diabetes-awareness-11788684